Atlas Trials

Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

Clinical trial NCT03123887 · COMPLETED

Trial details

NCT number
NCT03123887
Sponsor
Harbin Hematology and Oncology Institute
Status
COMPLETED
Study type
OBSERVATIONAL
B-precursor Acute Lymphoblastic Leukemia
Start date
2015-07-10
Primary completion
2016-06-03
Enrollment
632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.